By a vote of 128-22, the House adopted a budget amendment this week that would repeal the state’s so-called life sciences “gift ban” regulation. The need for reform in this area has become more acute in recent months given the detrimental impacts the regulations presents to our pharmaceutical, medical device, and health care sectors, as well as the forthcoming pre-emption of sections of the law by federal “Sunshine Act” reporting requirements.
Since the industry’s marketing code of conduct or “gift ban” was first proposed in 2008, the Chamber has worked closely with the state and industry leaders to secure improvements that ensure the competitiveness of our world-renowned life science and health care cluster. Our advocacy has sought to the preserve the essential collaboration and information-sharing between academic researchers and pharmaceutical, medical device, and health care industry professionals.
As this issue advances, the Chamber will continue working to promote a favorable regulatory climate for collaborative research and development, medical education, and product marketability in the life sciences.